SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-014898
Filing Date
2020-06-02
Accepted
2020-06-02 16:16:36
Documents
1
Period of Report
2020-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3947
  Complete submission text file 0000899243-20-014898.txt   5291
Mailing Address 161 WEST 61ST STREET NEW YORK NY 10022
Business Address
GOLDFISCHER CARL (Reporting) CIK: 0001110780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 20937142

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences